Literature DB >> 7524332

Expression of developmentally regulated muscle proteins in rhabdomyosarcomas.

L C Wijnaendts1, J C van der Linden, A J van Unnik, J F Delemarre, J P Barbet, G S Butler-Browne, C J Meijer.   

Abstract

Human skeletal muscle differentiation and maturation follows a precise sequence of events. To investigate whether and to what extent rhabdomyosarcoma (RMS) cells follow a comparable sequence, 29 fresh frozen specimens of RMS (14 primary and 15 relapses) were immunostained with antibodies directed against developmentally regulated myosin heavy chains (MHC), ie, fetal, fast, and slow MHC, in addition to desmin and vimentin. Four distinct patterns of expression were observed: I) RMS cells expressing exclusively vimentin and desmin (n = 7), II) in addition to expression of vimentin and desmin, a minority of neoplastic cells were immunoreactive with fetal MHC (n = 6), III) in addition to pattern II, fast MHC was expressed (n = 7), and IV) RMS cells simultaneously expressing vimentin, desmin, fetal, fast, and slow MHC (n = 9). Accordingly, the proportion of the MHC immunoreactive RMS cells increased gradually along with the four patterns of expression evolving from less than 25% up to 75% for fetal MHC, from less than 25% up to 50% for fast MHC, and up to 25% for slow MHC in the last category. Vimentin and desmin were coexpressed by almost all RMS cells. Double immunostaining revealed that comparable with the myogenic cells in the developing fetal skeletal muscle, expression of fetal MHC could be demonstrated in the same neoplastic cells either in conjunction with fast or slow MHC. In contrast, only in RMS, slow MHC expression in conjunction with fast MHC could be observed in the neoplastic cells. Neither the shape or size of neoplastic RMS cells, nor the histopathological types, nor tumor localization were related to the expression pattern of developmentally regulated MHC (fetal, fast, and slow MHC). These results confirm the commitment of the RMS cells to the myogenic pathway and demonstrate a restricted and aberrant differentiation pattern of the neoplastic cells in RMS compared with normal myogenesis, independent of histopathological types of RMS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524332      PMCID: PMC1887335     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Rhabdomyosarcoma: clinical and pathological features and comparison with human fetal and embryonal skeletal muscle.

Authors:  R B PATTON; R C HORN
Journal:  Surgery       Date:  1962-10       Impact factor: 3.982

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy.

Authors:  W M Molenaar; J W Oosterhuis; W A Kamps
Journal:  Hum Pathol       Date:  1984-10       Impact factor: 3.466

4.  Myosin and myoglobin as tumor markers in the diagnosis of rhabdomyosarcoma. A comparative study.

Authors:  A S Jong; M van Vark; C E Albus-Lutter; W van Raamsdonk; P A Voûte
Journal:  Am J Surg Pathol       Date:  1984-07       Impact factor: 6.394

5.  Mesenchymal and muscle-specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcomas.

Authors:  W M Molenaar; J W Oosterhuis; A M Oosterhuis; F C Ramaekers
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

6.  Fetal heavy chain skeletal myosin. An oncofetal antigen expressed by rhabdomyosarcoma.

Authors:  V Eusebi; F Rilke; C Ceccarelli; F Fedeli; S Schiaffino; G Bussolati
Journal:  Am J Surg Pathol       Date:  1986-10       Impact factor: 6.394

7.  Myosin isoform expression in rat rhabdomyosarcoma induced by Moloney murine sarcoma virus.

Authors:  G Azzarello; S Sartore; L Saggin; L Gorza; E D'Andrea; L Chieco-Bianchi; S Schiaffino
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

8.  Neonatal myosin heavy chains are not expressed in Ni-induced rat rhabdomyosarcoma.

Authors:  A C Borrione; A M Zanellato; L Saggin; M Mazzoli; G Azzarello; S Sartore
Journal:  Differentiation       Date:  1988-06       Impact factor: 3.880

9.  Immunocytochemistry of rhabdomyosarcoma. The use of four different markers.

Authors:  V Eusebi; C Ceccarelli; L Gorza; S Schiaffino; G Bussolati
Journal:  Am J Surg Pathol       Date:  1986-04       Impact factor: 6.394

10.  Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma.

Authors:  H Mullink; S C Henzen-Logmans; J J Alons-van Kordelaar; T M Tadema; C J Meijer
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.